V. Goldstraw, P. Crowley, J. Chansky, K. Giroux, D. Groome et al., The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours, Journal of Thoracic Oncology, vol.2, issue.8, pp.706-720, 2007.
DOI : 10.1097/JTO.0b013e31812f3c1a

W. Wever, Y. Vankan, S. Stroobants, and J. Verschakelen, Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer, European Respiratory Journal, vol.29, issue.5, pp.995-1002, 2007.
DOI : 10.1183/09031936.00119106

B. Fischer, U. Lassen, J. Mortensen, S. Larsen, A. Loft et al., Preoperative Staging of Lung Cancer with Combined PET???CT, New England Journal of Medicine, vol.361, issue.1, pp.32-41, 2009.
DOI : 10.1056/NEJMoa0900043

J. Pignon, H. Tribodet, G. Scagliotti, J. Douillard, F. Shepherd et al., Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group, Journal of Clinical Oncology, vol.26, issue.21, pp.3552-3561, 2008.
DOI : 10.1200/JCO.2007.13.9030

N. Group, Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. The Lancet. 16 avr, pp.1267-77, 2010.

K. Furuse, M. Fukuoka, M. Kawahara, H. Nishikawa, Y. Takada et al., Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.17, issue.9, pp.2692-2692, 1999.
DOI : 10.1200/JCO.1999.17.9.2692

W. Curran, R. Paulus, C. Langer, R. Komaki, J. Lee et al., Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410, JNCI Journal of the National Cancer Institute, vol.20, issue.20, pp.1452-60, 2011.
DOI : 10.1200/JCO.2002.03.054

P. Zatloukal, L. Petruzelka, M. Zemanova, L. Havel, F. Janku et al., Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study, Lung Cancer, vol.46, issue.1, pp.87-98, 2004.
DOI : 10.1016/j.lungcan.2004.03.004

. Concomitant-radio-chemotherapy, RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs): A1-05, S310. 13. Gandara DR, 2007.

T. Seiwert, P. Connell, A. Mauer, P. Hoffman, C. George et al., A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non-Small Cell Lung or Esophageal Cancer, Clinical Cancer Research, vol.13, issue.2, pp.515-537, 2007.
DOI : 10.1158/1078-0432.CCR-06-1058

H. Choy, R. Macrae, E. Vokes, J. Herndon, M. Kelley et al., The current state of paclitaxel and radiation in the combinedmodality therapy of non-small cell lung cancer Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non?Small-Cell Lung Cancer: Cancer and Leukemia Group B, Semin Oncol. août J Clin Oncol. 5 janv, vol.2825, issue.1713, pp.17-221698, 2001.

C. Belani, J. Barstis, M. Perry, R. Rocca, S. Nattam et al., Multicenter, Randomized Trial for Stage IIIB or IV Non???Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation, Journal of Clinical Oncology, vol.21, issue.15, pp.2933-2942, 2003.
DOI : 10.1200/JCO.2003.02.563

C. Belani, H. Choy, P. Bonomi, C. Scott, P. Travis et al., Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non???Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol, Journal of Clinical Oncology, vol.23, issue.25, pp.5883-91, 2005.
DOI : 10.1200/JCO.2005.55.405

P. Fournel, A. Vernengegre, R. G. Arellano, A. Massutí, B. Andreu et al., Induction or consolidation chemotherapy with cisplatin and paclitaxel plus concurrent chemoradiation with carboplatin and vinorelbine for unresectable non-small cell lung cancer patients: Randomized phase-II trial GFPC-GLOT-IFCT 02-01 Randomized phase II trial using concomitant chemoradiation plus induction (I) or consolidation (C) chemotherapy (CT) for unresectable stage III non-small cell lung cancer (NSCLC) patients (p) Mature results of the SLCG 0008 study, J Clin Oncol. J Thorac Oncol. août, vol.242, pp.3-5, 2006.

K. Kelly, K. Chansky, L. Gaspar, K. Albain, J. Jett et al., Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non???Small-Cell Lung Cancer: SWOG S0023, Journal of Clinical Oncology, vol.26, issue.15, pp.2450-62312, 2008.
DOI : 10.1200/JCO.2007.14.4824

F. Mornex, S. Danhier, and P. Van-houtte, Cancers bronchiques non à petites cellules : toxicité de l'association radiothérapie-chimiothérapie. Revue de la littérature, Bull Cancer (Paris), vol.81, issue.1, pp.5-13, 1994.

. Standards, Options et Recommandations pour la prise en charge thérapeutique des patients atteints d'un cancer bronchopulmonaire primitif non à petites cellules localement avancé, Bull Cancer, vol.88, issue.4, pp.369-87, 2001.

J. Armstrong, C. Burman, S. Leibel, D. Fontenla, G. Kutcher et al., Threedimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer Application of the quality index methodology for dosimetric verification of build-up effect beyond air?tissue interface in treatment planning system algorithms, Int J Radiat Oncol Biol Phys. Radiother Oncol, vol.2679, issue.282, pp.685-9208, 1993.

J. Hayman, M. Martel, R. Haken, D. Normolle, R. Todd et al., Dose Escalation in Non???Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial, Journal of Clinical Oncology, vol.19, issue.1, pp.127-163, 2001.
DOI : 10.1200/JCO.2001.19.1.127

J. Vansteenkiste, D. Leyn, P. Deneffe, G. Stalpaert, G. Nackaerts et al., Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases, The Annals of Thoracic Surgery, vol.63, issue.5, pp.1441-50, 1997.
DOI : 10.1016/S0003-4975(97)00314-7

S. Yuan, X. Meng, J. Yu, D. Mu, K. Chao et al., Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non???small-cell lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.67, issue.3, pp.727-761, 2007.
DOI : 10.1016/j.ijrobp.2006.08.057

P. Jenkins, R. Milliner, and P. Latimer, Shrinkage of Locally Advanced Non???Small-Cell Lung Cancers in Response to Induction Chemotherapy: Implications for Radiotherapy Treatment Planning, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.4, pp.993-1000, 2007.
DOI : 10.1016/j.ijrobp.2007.05.058

C. Greco, K. Rosenzweig, G. Cascini, O. Tamburrini, W. Eberhardt et al., Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC) Lung Cancer ESMO Consensus Conference in Lung Cancer: locally-advanced stage III nonsmall-cell lung cancer (NSCLC) Ann Oncol Concurrent chemoradiotherapy in non-small cell lung cancer, Disponible sur, pp.125-34591, 2007.

J. Bradley, R. Paulus, R. Komaki, G. Masters, K. Forster et al., A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617 ASCO Meet Abstr GILT study: Oral vinorelbine (NVBo) and cisplatin (P) with concomitant radiotherapy (RT) followed by either consolidation (C) with NVBo plus P plus best supportive care (BSC) or BSC alone in stage (st) III non-small cell lung cancer (NSCLC): Final results of a phase (ph) III study, pp.7001-7044, 2012.

L. Wang, S. Wu, G. Ou, N. Bi, W. Li et al., Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer, Lung Cancer, vol.77, issue.1, pp.89-96, 2012.
DOI : 10.1016/j.lungcan.2012.02.011

P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, and R. Ford, IIIB non? small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019, Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage Services H, others. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), pp.3454-60, 2002.